John M. Gill
2017
In 2017, John M. Gill earned a total compensation of $492.2K as Former Chief Executive Officer of PharmAthene at PharmAthene, a 71% decrease compared to previous year.
Compensation breakdown
| Bonus | $303,150 |
|---|---|
| Option Awards | $32,000 |
| Salary | $106,812 |
| Other | $50,273 |
| Total | $492,235 |
Gill received $303.2K in bonus, accounting for 62% of the total pay in 2017.
Gill also received $32K in option awards, $106.8K in salary and $50.3K in other compensation.
Rankings
In 2017, John M. Gill's compensation ranked 11,945th out of 14,666 executives tracked by ExecPay. In other words, Gill earned more than 18.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,945 out of 14,666 | 19th |
Division Manufacturing | 4,707 out of 5,772 | 19th |
Major group Chemicals And Allied Products | 1,718 out of 2,075 | 17th |
Industry group Drugs | 1,423 out of 1,731 | 18th |
Industry Pharmaceutical Preparations | 1,109 out of 1,333 | 17th |
Source: SEC filing on July 26, 2018.
Gill's colleagues
We found three more compensation records of executives who worked with John M. Gill at PharmAthene in 2017.